Türkiye’de koronavirüsten günlük can kaybı 222, vaka sayısı 29 bin 136

2BEHRJJ (200414) -- BEIJING, April 14, 2020 (Xinhua) -- A staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing, capital of China, March 16, 2020. China has approved two COVID-19 inactivated vaccine candidates for clinical trials, according to the State Council joint prevention and control mechanism against the coronavirus Tuesday. The two vaccine candidates are developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group (Sinopharm) and Sinovac Research and Development Co., Ltd, a company based in Beijing. Clinical

Sağlık Bakanı Fahrettin Koca, koronavirüs salgınında son durumu paylaştı. Bugün 29 bin 136 yeni vaka tespit edildi, 222 hasta ise hayatını kaybetti.